Catinazzo Thomas
SEC CIK 1818261 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | SVP, Fin | 122.9K | — | $8.87M | 55 | 2021-09-13 | 2026-09-08 |
Most active insiders at RLAY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SVF Pauling (Cayman) Ltd | 10% | — | $116.40M |
| 2 | Catinazzo Thomas | CFO | — | $5.18M |
| 3 | Patel Sanjiv | Pres, CEO, Dir | — | $3.61M |
| 4 | Bergstrom Donald A | Pres, R, D | — | $2.36M |
| 5 | Rahmer Peter | See remarks | — | $1.47M |
Transactions 55
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-09 16:15 | 2026-09-08 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $18.94 | -17.7K | 122.9K | -13% | -$335.6K |
| T | 2026-08-18 16:16 | 2026-08-14 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $19.74 | -17.7K | 140.6K | -11% | -$349.7K |
| 2026-07-30 16:13 | 2026-07-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $18.61 | -1,459 | 158.3K | -0.9% | -$27.2K | |
| T | 2026-07-08 17:07 | 2026-07-06 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $18.69 | -17.7K | 159.7K | -10% | -$331.1K |
| DMT | 2026-06-24 16:09 | 2026-06-22 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale+OE | $16.97 | -187.2K | 177.5K | -51% | -$3.18M |
| DMT | 2026-06-24 16:09 | 2026-06-22 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | M - OptEx | $4.93 | +169.4K | 229.0K | +284% | +$834.7K |
| T | 2026-05-14 18:44 | 2026-05-14 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $12.86 | -17.7K | 195.2K | -8% | -$227.8K |
| 2026-04-30 16:22 | 2026-04-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $14.79 | -972 | 212.9K | -0.5% | -$14.4K | |
| DMT | 2026-04-09 20:55 | 2026-04-07+ | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale+OE | $13.19 | -19.5K | 213.9K | -8% | -$257.5K |
| DT | 2026-04-09 20:55 | 2026-04-09 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | M - OptEx | $5.22 | +1,800 | 215.7K | +0.8% | +$9,396 |
| T | 2026-03-11 | 2026-03-09 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $10.06 | -17.7K | 231.6K | -7% | -$178.2K |
| M | 2026-01-29 | 2026-01-27+ | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $7.71 | -15.5K | 249.3K | -6% | -$119.6K |
| 2025-10-30 | 2025-10-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $7.29 | -21.7K | 313.6K | -6% | -$157.9K | |
| M | 2025-07-30 | 2025-07-28+ | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $3.69 | -20.1K | 335.3K | -6% | -$74.0K |
| MT | 2025-04-30 | 2025-04-28+ | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $3.07 | -19.2K | 368.3K | -5% | -$58.8K |
| MT | 2025-03-31 | 2025-03-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $2.84 | -4,864 | 379.1K | -1% | -$13.8K |
| MT | 2025-01-30 | 2025-01-28+ | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $4.55 | -58.9K | 263.2K | -18% | -$268.3K |
| T | 2025-01-30 | 2025-01-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | A - Grant | $0.00 | +139.1K | 402.3K | +53% | $0 |
| MT | 2024-12-31 | 2024-12-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $4.42 | -4,865 | 303.8K | -2% | -$21.5K |
| MT | 2024-10-30 | 2024-10-28+ | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $6.03 | -9,102 | 311.5K | -3% | -$54.9K |
| MT | 2024-10-01 | 2024-09-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $7.46 | -6,457 | 313.2K | -2% | -$48.2K |
| MT | 2024-07-31 | 2024-07-29 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $8.56 | -10.8K | 319.6K | -3% | -$92.3K |
| MT | 2024-07-01 | 2024-06-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $6.24 | -9,373 | 330.4K | -3% | -$58.5K |
| 2024-04-29 | 2024-04-29 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $6.38 | -1,695 | 339.8K | -0.5% | -$10.8K | |
| 2024-03-29 | 2024-03-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $7.70 | -348 | 341.5K | -0.1% | -$2,680 | |
| 2024-01-31 | 2024-01-29 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $9.64 | -2,005 | 341.8K | -0.6% | -$19.3K | |
| 2024-01-18 | 2024-01-16 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | A - Grant | $0.00 | +200.0K | 343.9K | +139% | $0 | |
| 2023-12-29 | 2023-12-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $11.51 | -294 | 143.9K | -0.2% | -$3,384 | |
| 2023-11-01 | 2023-10-30 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $6.03 | -1,697 | 144.1K | -1% | -$10.2K | |
| 2023-09-29 | 2023-09-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $8.38 | -294 | 145.8K | -0.2% | -$2,464 | |
| 2023-07-31 | 2023-07-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $11.80 | -1,693 | 146.1K | -1% | -$20.0K | |
| 2023-06-28 | 2023-06-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $12.12 | -294 | 147.8K | -0.2% | -$3,563 | |
| A | 2023-06-01 | 2023-04-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $11.16 | -2,012 | 148.1K | -1% | -$22.5K |
| 2023-05-01 | 2023-04-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $11.16 | -863 | 149.3K | -0.6% | -$9,631 | |
| 2023-03-28 | 2023-03-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $15.36 | -347 | 150.1K | -0.2% | -$5,330 | |
| 2023-01-31 | 2023-01-30 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $21.56 | -864 | 150.5K | -0.6% | -$18.6K | |
| D | 2023-01-19 | 2023-01-17 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | A - Grant | $0.00 | +101.1K | 151.3K | +201% | $0 |
| 2022-12-28 | 2022-12-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $14.49 | -445 | 50.2K | -0.9% | -$6,448 | |
| 2022-11-01 | 2022-10-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $21.54 | -1,099 | 50.7K | -2% | -$23.7K | |
| 2022-09-29 | 2022-09-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $22.73 | -443 | 51.8K | -0.8% | -$10.1K | |
| D | 2022-09-08 | 2022-09-08 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale+OE | $30.00 | -26.3K | 52.2K | -33% | -$787.7K |
| D | 2022-09-08 | 2022-09-08 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | M - OptEx | $4.12 | +26.3K | 78.5K | +50% | +$108.2K |
| 2022-07-29 | 2022-07-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $21.26 | -734 | 52.2K | -1% | -$15.6K | |
| 2022-06-28 | 2022-06-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $20.31 | -300 | 53.0K | -0.6% | -$6,093 | |
| 2022-05-02 | 2022-04-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $25.57 | -725 | 53.3K | -1% | -$18.5K | |
| 2022-03-31 | 2022-03-29 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $29.87 | -282 | 54.0K | -0.5% | -$8,423 | |
| D | 2022-03-28 | 2022-03-24 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale+OE | $30.00 | -13.3K | 54.3K | -20% | -$398.6K |
| D | 2022-03-28 | 2022-03-24 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | M - OptEx | $4.12 | +13.3K | 67.5K | +24% | +$54.7K |
| D | 2022-01-31 | 2022-01-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | A - Grant | $0.00 | +39.3K | 54.3K | +262% | $0 |
| 2021-12-27 | 2021-12-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | SVP, Fin | S - Sale | $33.10 | -295 | 15.0K | -2% | -$9,764 | |
| D | 2021-11-16 | 2021-11-15 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | SVP, Fin | M - OptEx | $4.12 | +22.5K | 37.8K | +147% | +$92.7K |
| D | 2021-11-16 | 2021-11-15 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | SVP, Fin | S - Sale+OE | $35.40 | -22.5K | 15.3K | -60% | -$796.5K |
| 2021-09-27 | 2021-09-27 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | SVP, Fin | S - Sale | $36.87 | -293 | 15.3K | -2% | -$10.8K | |
| D | 2021-09-13 | 2021-09-13 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | SVP, Fin | M - OptEx | $4.12 | +22.5K | 38.1K | +144% | +$92.7K |
| D | 2021-09-13 | 2021-09-13 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | SVP, Fin | S - Sale+OE | $35.00 | -22.5K | 15.6K | -59% | -$787.5K |
Purchase Sale Sale after option exercise All abbreviations